Literature DB >> 11244502

Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme.

T Tsuji1, S Usui, T Aida, T Tachikawa, G F Hu, A Sasaki, T Matsumura, R Todd, D T Wong.   

Abstract

The hamster ornithine decarboxylase antizyme (ODC-Az) cDNA was transfected into the hamster malignant oral keratinocyte cell line, HCPC-1. Ectopic expression of ODC-Az resulted in the reversion of malignant phenotypes and alteration of DNA methylation status of CCGG sites. The phenotypes examined include ODC enzymatic activity, doubling time, morphological change, anchorage dependent growth, tumorigenicity in nude mice, induction of epithelial differentiation marker protein (involucrin), and change of cell cycle position. Comparison of CCGG DNA methylation status of the ODC-Az and control vector transfectants revealed a significant increase in demethylation of 5-methyl cytosines (m5C) of CCGG sites in the ODC-Az transfectants. Ectopic expression of ODC-Az gene in hamster malignant oral keratinocytes led to reduce ODC activity and the subsequent demethylation of 5-methyl cytosines, presumably via the ODC/ polyamines/ decarboxylated S-adenosylmethionine (dc-AdoMet) pathways. Our data suggest that ODC-Az shared the same pathway of polyamines/ dc-AdoMet/DNA methyltransferase (DNA MTase). We propose that ODC-Az mediates a novel mechanism in tumor suppression by DNA demethylation and presumably re-activation of key cellular genes silenced by DNA hypermethylation during cancer development. Oncogene (2001) 20, 24 - 33.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244502     DOI: 10.1038/sj.onc.1204051

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Antizyme affects cell proliferation and viability solely through regulating cellular polyamines.

Authors:  Zippi Bercovich; Zohar Snapir; Alona Keren-Paz; Chaim Kahana
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

Review 3.  Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.

Authors:  Rachelle R Olsen; Bruce R Zetter
Journal:  Mol Cancer Res       Date:  2011-08-17       Impact factor: 5.852

4.  Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomes.

Authors:  Christopher Kasbek; Ching-Hui Yang; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

5.  Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line.

Authors:  Daisuke Yamamoto; Kaori Shima; Kou Matsuo; Takashi Nishioka; Chang Yan Chen; Guo-Fu Hu; Akira Sasaki; Takanori Tsuji
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

6.  Antizyme mRNA distribution and regulation in rat small intestinal enterocytes.

Authors:  J E Gill; J F Christian; E R Seidel
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

7.  Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients.

Authors:  Yi-Shing Lisa Cheng; Lee Jordan; Terry Rees; Huey-Shys Chen; Lance Oxford; Ole Brinkmann; David Wong
Journal:  Clin Oral Investig       Date:  2013-07-28       Impact factor: 3.573

8.  Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.

Authors:  Y-S L Cheng; L Jordan; H-S Chen; D Kang; L Oxford; J Plemons; H Parks; T Rees
Journal:  J Periodontal Res       Date:  2016-08-23       Impact factor: 4.419

9.  Suppression of LFA-1 expression by spermine is associated with enhanced methylation of ITGAL, the LFA-1 promoter area.

Authors:  Yoshihiko Kano; Kuniyasu Soda; Fumio Konishi
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 10.  The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

Authors:  John P Alao
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.